CoChat

Cost-effectiveness of a European preventive cardiology programme in primary care: a Markov modelling approach

Open access
Mistry, Hema, Morris, Stephen, Dyer, Matthew, Kotseva, Kornelia, Wood, David, Buxton, Martin · 2012 · BMJ Open

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Abstract

Objective: To investigate the longer-term cost-effectiveness of a nurse-coordinated preventive cardiology programme for primary prevention of cardiovascular disease (CVD) compared to routine practice from a health service perspective. Design: A matched, paired cluster-randomised controlled trial. Setting: Six pairs of general practices in six countries. Participants: 1019 patients were randomised to the EUROACTION intervention programme and 1005 patients to usual care (UC) and who completed the 1-year follow-up. Outcome measures: Evidence on health outcomes and costs was based on patient-level data from the study, which had a 1-year follow-up period. Future risk of CVD events was modelled, using published risk models based on patient characteristics. An individual-level Markov model for each patient was used to extrapolate beyond the end of the trial, which was populated with data from published sources. We used an 11-year time horizon and investigated the impact on the cost-effectiveness of varying the duration of the effect of the intervention beyond the end of the trial. Results are expressed as incremental cost per quality-adjusted life-year gained. Results: Unadjusted results found the intervention to be more costly and also more effective than UC. However, after adjusting for differences in age, gender, country and baseline risk factors, the intervention was dominated by UC, but this analysis was not able to take into account the lifestyle changes in terms of diet and physical activity. Conclusions: Although the EUROACTION study achieved healthier lifestyle changes and improvements in management of blood pressure and lipids for patients at high risk of CVD, compared to UC, it was not possible to show, using available risk equations which do not incorporate diet and physical activity, that the intervention reduced longer-term cardiovascular risk cost-effectively. Whether or not an intervention such as that offered by EUROACTION is cost-effective requires a longer-term trial with major cardiovascular events as the outcome. Trial Registration number: ISRCTN 71715857.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmjopen-2012-001029

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 (A) One-year observed costs for the intervention and usual care groups split by type. EA, EuroAction costs; Other HC, other health care costs; Drugs, cardiac-related medication costs; Cardiac, cardiac procedure costs. (B) Mean costs for the intervention and usual care groups for the main health states in the Markov model.
Figure 1 (A) One-year observed costs for the intervention and usual care groups split by type. EA, EuroAction costs; Other HC, other health care costs; Drugs, cardiac-related medication costs; Cardiac, cardiac procedure costs. (B) Mean costs for the intervention and usual care groups for the main health states in the Markov model.CC BY-NC · PubMed Central
Figure 2 Cost-effectiveness acceptability curves. (A) Unadjusted results. (B) Adjusted results. *Adjusted for differences between groups by age, gender, country and baseline risk factors.
Figure 2 Cost-effectiveness acceptability curves. (A) Unadjusted results. (B) Adjusted results. *Adjusted for differences between groups by age, gender, country and baseline risk factors.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 21 references

Cited by

See all 50

Metadata

Authors
Mistry, H., Morris, S., Dyer, M., Kotseva, K., Wood, D., & Buxton, M.
Affiliations
  • Brunel University of London (GB)
  • Department of Applied Health Research, University College London, London, UK
  • National Institute for Health and Care Excellence (GB)
  • Imperial College London (GB)
Corresponding author
Mistry, Hema
Venue
BMJ Open
Publisher
BMJ
Published
2012
Volume
2
Issue
5
Pages
e001029
ISSN
2044-6055 (ISSN-L)
OpenAlex
W2139786027
Cited by
48
References
21
Citations by year
2024: 2 · 2022: 4 · 2021: 13 · 2020: 2 · 2019: 1 · 2018: 3 · 2017: 8 · 2016: 10 · 2013: 3 · 2012: 1
FWCI
1.24
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • BMJ Open (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Warwick Research Archive Portal (University of Warwick) (acceptedVersion)
  • Brunel University Research Archive (BURA) (Brunel University London) (submittedVersion, cc-by-nc)
  • UCL Discovery (University College London) (submittedVersion)
  • HighWire Press Open Archive (submittedVersion)
  • Spiral (Imperial College London) (submittedVersion, cc-by-nc)
Funders
European Society of Cardiology
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
Keywords
cost-effectiveness, preventive cardiology, cardiovascular disease prevention, primary care, cardiovascular risk, Markov model, quality-adjusted life years, blood pressure control, lipid control, lifestyle modification, diet and physical activity, risk prediction model

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cost-effectiveness of a European preventive cardiology programme in primary care: a Markov modelling approach. https://app.cochat.ai/papers/10.1136/bmjopen-2012-001029
The paper
Mistry, H., Morris, S., Dyer, M., Kotseva, K., Wood, D., & Buxton, M. (2012). Cost-effectiveness of a European preventive cardiology programme in primary care: a Markov modelling approach. BMJ Open. https://doi.org/10.1136/bmjopen-2012-001029

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.